• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Wednesday, June 24, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Chemistry

Sandia Fellow wins nuclear fusion award

Bioengineer by Bioengineer
January 21, 2020
in Chemistry
Reading Time: 3 mins read
0
IMAGE
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

IMAGE

Credit: Randy Montoya, Sandia National Laboratories

ALBUQUERQUE, N.M. — Sandia National Laboratories Fellow Keith Matzen has been awarded the 2019 Distinguished Career Award by Fusion Power Associates, a national nonprofit research and educational foundation, for his many contributions to the laboratory development of nuclear fusion.

The foundation annually brings together senior U.S. and international fusion experts to review the status of fusion research and consider ways to move forward. Its goal is to provide timely information on the status of fusion development and other applications of plasma science. Matzen was honored at the group’s annual meeting in Washington, D.C., in December.

“For many years at Los Alamos, I knew the name Keith Matzen as being synonymous with pulsed power ICF (inertial confinement fusion). This honor is well deserved, given Keith’s many years of contribution to both ICF and to Sandia,” said Sandia Associate Laboratories Director Susan Seestrom, the labs’ chief research officer.

Inertial confinement fusion creates energy by rapidly heating and compressing a fuel target, typically in the form of a pellet that most often contains a mixture of deuterium and tritium.

Among Matzen’s many achievements was his proposal and subsequent leadership in the mid-1990s to convert the Sandia particle-beam fusion accelerator known as PBFA-II to the pulsed-power machine now referred to, worldwide, as Z. Less than two months after the completed conversion in 1996, Z — which makes use of a powerful magnetic field that accompanies its large electrical current — established worldwide record levels of X-ray energy and power during its nanoseconds-long implosions called Z-pinches. (“Z” because the implosion takes place in the vertical plane.)

Z experiments have provided insights into the properties of materials at extreme temperature and pressure conditions, the effects of intense radiation on materials and thermonuclear fusion in both national security applications and in astrophysics and planetary science. Z’s efficient delivery of energy to fusion targets has made the method called “pulsed-power, magnetic direct drive” a strong candidate for ultimately achieving high-yield fusion in the laboratory, a goal of scientists worldwide.

Matzen’s other varied achievements

While a manager at Z, Matzen recruited and mentored scientists whom he encouraged to innovate and take technical risks, which proved effective in stimulating new ideas. More than 90% of the experiments conducted on Z today were not envisioned when PBFA II was converted to Z.

As director of Sandia’s pulsed-power sciences, Matzen oversaw the refurbishment of Z, a $90 million project completed in 2007 on time and on budget.

Matzen grew up in Nebraska and earned a doctorate in molecular kinetic theory from Iowa State University. He was elected a fellow of the American Physical Society in 1997. In 2011, he was presented with the Fusion Power Associates Leadership Award.

He was appointed Sandia Fellow in 2018. Only 15 Sandia employees have achieved that rank in the 70-year history of the laboratories.

###

Sandia National Laboratories is a multimission laboratory operated by National Technology and Engineering Solutions of Sandia LLC, a wholly owned subsidiary of Honeywell International Inc., for the U.S. Department of Energy’s National Nuclear Security Administration. Sandia Labs has major research and development responsibilities in nuclear deterrence, global security, defense, energy technologies and economic competitiveness, with main facilities in Albuquerque, New Mexico, and Livermore, California.

Sandia news media contact: Neal Singer, [email protected], 505-845-7078

Media Contact
Neal Singer
[email protected]
505-845-7078

Tags: AstrophysicsChemistry/Physics/Materials SciencesResearch/DevelopmentWeaponry
Share12Tweet8Share2ShareShareShare2

Related Posts

Electric Field and Oxygen Spillover Collaborate to Control Electrode Migration in SOECs

June 24, 2026
Innovative Speckle-Based Metrology System Advances Precision Measurement of Next-Generation X-Ray Mirrors — Chemistry

Innovative Speckle-Based Metrology System Advances Precision Measurement of Next-Generation X-Ray Mirrors

June 24, 2026

Water-Activated PVA Film Transforms from Bioplastic to High-Performance Wood Adhesive

June 24, 2026

SwRI and St. Mary’s University Partner to Forecast Durability of Metal Hydride Hydrogen Storage

June 24, 2026
Please login to join discussion

POPULAR NEWS

  • Saying Goodbye to PGY-6: Pediatric Fellowship Realities

    103 shares
    Share 41 Tweet 26
  • Multi-Hospital Study Reveals Long Covid Burden Is Twice as High as Current Estimates

    92 shares
    Share 36 Tweet 23
  • Detection of EDCs in Breast Milk and Infant Urine Up to Six Months Highlights Early Exposure Risks

    77 shares
    Share 31 Tweet 19
  • New Drug Candidate Developed at McMaster Shows Potential for Treating Brain Cancer

    58 shares
    Share 23 Tweet 15

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Neutrophil S100A8/A9 Hinders Megakaryocyte Maturation

Robotic Hand That “Feels” Motion: International Study Uncovers How the Brain Detects Movement

Unveiling the Impact of TP53 Mutations in Oral Cancer: Molecular Insights and Prognostic Significance

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 82 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.